{"date":"2026-01-23","count":11,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6919-2026-01-23-2356-10jdlmt","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-01-23","time":"23:56:13","subject":"本公司新藥CBL-514注射劑合併tirzepatide (Eli Lilly)之多中心二期臨床試驗申請，擬依FDA建議將適應症由「體重管理」修改為「減少皮下脂肪」並重新送件。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-01-23 23:56，「本公司新藥CBL-514注射劑合併tirzepatide (Eli Lilly)之多中心二期臨床試驗申請，擬依FDA建議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-01-23-1855-a267sd","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-01-23","time":"18:55:14","subject":"本公司美國子公司Foresee USA向韓國食品藥物安全部(MFDS)提交創新藥MMP-12抑制劑Linvemastat(FP-020)用於治療氣喘之二期臨床試驗申請","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-01-23 18:55，「本公司美國子公司Foresee USA向韓國食品藥物安全部(MFDS)提交創新藥MMP-12抑制劑Linvemastat」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2026-01-23-1852-1xet93t","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2026-01-23","time":"18:52:43","subject":"公告本公司一年內累積處分同一有價證券達實收資本額20%","clause":"第20款","fact_date":"2026-01-23","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2026-01-23 18:52，「公告本公司一年內累積處分同一有價證券達實收資本額20%」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-01-23-1758-1eac7sx","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-01-23","time":"17:58:04","subject":"本公司董事會決議發行115年度員工認股權憑證","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-01-23 17:58，「本公司董事會決議發行115年度員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-01-23-1742-11vxjjv","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-01-23","time":"17:42:04","subject":"本公司114年現金增資股款催繳公告","clause":"第51款","fact_date":"2026-01-23","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-01-23 17:42，「本公司114年現金增資股款催繳公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-01-23-1527-1xv18rp","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-01-23","time":"15:27:09","subject":"代重要子公司AMI公告辦理現金增資發行新股事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-01-23 15:27，「代重要子公司AMI公告辦理現金增資發行新股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-01-23-1520-ttc28i","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-01-23","time":"15:20:55","subject":"代重要子公司Medeon International, Inc.公告辦理現金增資發行新股事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-01-23 15:20，「代重要子公司Medeon International, Inc.公告辦理現金增資發行新股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-01-23-1511-1v89vf8","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-01-23","time":"15:11:48","subject":"公告本公司買回庫藏股期間屆滿執行情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-01-23 15:11，「公告本公司買回庫藏股期間屆滿執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2026-01-23-1501-1la36wq","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2026-01-23","time":"15:01:52","subject":"代重要子公司GOODEAL ENTERPRISES LIMITED公告辦理減資變更登記完成","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2026-01-23 15:01，「代重要子公司GOODEAL ENTERPRISES LIMITED公告辦理減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-01-23-1354-1qkz1x4","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-01-23","time":"13:54:27","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-01-23 13:54，「代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-01-23-1353-124ffeh","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-01-23","time":"13:53:53","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-01-23 13:53，「代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}